Diabetes decisions — 2025

The appeal for service connection for various conditions and a compensable rating for bilateral hearing loss is dismissed due to the Veteran's death.

The Board granted an effective date of February 24, 2010, for the grant of a TDIU based on the Veteran's service-connected PTSD and type II diabetes mellitus.

The appeal was dismissed due to the Veteran's death during the pendency of the appeal.

The Board granted an effective date of April 10, 2009, for the grant of service connection for DM2, prostate cancer, erectile dysfunction associated with prostate cancer, and SMC based on loss of use of a creative organ.

The Board granted service connection for type II diabetes mellitus, multiple myeloma, and peripheral neuropathy of the bilateral upper and lower extremities based on in-service exposure to herbicide agents.

The Veteran's chronic fatigue syndrome (CFS) is granted under the PACT Act, but other conditions are remanded for further review.

The appeal seeking an earlier effective date for service connection for diabetes mellitus is dismissed, while entitlement to an effective date of January 29, 2020, but no earlier, for service connection for dry eye syndrome with history of vitreous heme and resolved pseudophakia is granted.

The Board granted an earlier effective date for diabetes mellitus type II and service connection for GERD, while denying increased ratings for lung cancer, hypertension, and hearing loss, among other issues.

The Board vacated its February 12, 2025 decision and denied the veteran's claims for increased ratings and earlier effective dates.

The Board denied service connection for a skin condition, diabetes mellitus, type II, migraines/headaches, and hypertension as the evidence did not support a finding that these conditions were related to the Veteran's period of active duty service.

The Board remands the claims for service connection for chronic kidney disease, diabetes mellitus type 2 with diabetic CKD hyperglycemic, and diabetic neuropathy to obtain additional evidence.

The Board denied service connection for diabetes mellitus, type 2, finding that the evidence did not support a link between the Veteran's in-service exposure and his current condition.

The Board denied the veteran's appeals for increased ratings for PTSD and diabetes mellitus, type II.

The Board granted service connection for diabetes mellitus and related conditions, including diabetic neuropathy of the upper and lower extremities, erectile dysfunction, hypertension, retinopathy, and carpal tunnel syndrome (CTS), based on herbicide exposure during service.

The Veteran has withdrawn all remaining appeals under this docket, and the claims for service connection for PTSD, bilateral hearing loss, diabetes mellitus II, and sinusitis are dismissed.

The Board granted earlier effective dates for the grants of service connection for chronic kidney disease, diabetes mellitus type II, diabetic peripheral neuropathy of all extremities, hypertension, and coronary artery disease, but denied earlier effective dates for bilateral hearing loss and surgical scar of the low back, midline. The Board also remanded claims for service connection for various disabilities.

The Board dismissed the issues of entitlement to service connection for diabetes mellitus and hypertension due to a claims processing error.

The Board remands the claims for service connection for diabetes mellitus, type II and obstructive sleep apnea to obtain additional medical opinions.

The Board granted service connection for gastroesophageal reflux disease (GERD) as secondary to the Veteran's service-connected musculoskeletal disabilities, but remanded the claim for diabetes mellitus type II due to insufficient evidence.

The Board denied the Veteran's claims for an increased rating for tinnitus and service connection for diabetes mellitus, type 2 (diabetes), finding no evidence of a current disability related to service or secondary to any service-connected condition.